NVRS — Noveris Health Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$102.46m
- CA$112.03m
Annual cashflow statement for Noveris Health Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.6 | -17.2 | -20.9 | -3.15 | 2.92 |
| Depreciation | |||||
| Non-Cash Items | 3.89 | 0.474 | 11.4 | 0.752 | -3.34 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.59 | 8.21 | 5.3 | 2.36 | 0.426 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -24.1 | -8.43 | -4.22 | -0.037 | 0.009 |
| Capital Expenditures | -0.291 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.182 | -0.038 | 0.525 | 0 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.474 | -0.038 | 0.525 | 0 | — |
| Financing Cash Flow Items | -0.76 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.8 | 6.98 | 3.72 | 0 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.695 | -1.48 | 0.027 | -0.037 | 0.009 |